These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

999 related items for PubMed ID: 18245400

  • 1. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
    Farhath S, He Z, Nakhla T, Saslow J, Soundar S, Camacho J, Stahl G, Shaffer S, Mehta DI, Aghai ZH.
    Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
    [Abstract] [Full Text] [Related]

  • 2. Pepsin, a reliable marker of gastric aspiration, is frequently detected in tracheal aspirates from premature ventilated neonates: relationship with feeding and methylxanthine therapy.
    Farhath S, Aghai ZH, Nakhla T, Saslow J, He Z, Soundar S, Mehta DI.
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):336-41. PubMed ID: 16954956
    [Abstract] [Full Text] [Related]

  • 3. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J, Beharry KD, Valencia AM, Strauss A, Modanlou HD.
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [Abstract] [Full Text] [Related]

  • 4. Association of gastric fluid microbes at birth with severe bronchopulmonary dysplasia.
    Oue S, Hiroi M, Ogawa S, Hira S, Hasegawa M, Yamaoka S, Yasui M, Tamai H, Ogihara T.
    Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F17-22. PubMed ID: 18676413
    [Abstract] [Full Text] [Related]

  • 5. IFN-γ and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia.
    Aghai ZH, Saslow JG, Mody K, Eydelman R, Bhat V, Stahl G, Pyon K, Bhandari V.
    Pediatr Pulmonol; 2013 Jan; 48(1):8-13. PubMed ID: 22431160
    [Abstract] [Full Text] [Related]

  • 6. Sirtuin1 in tracheal aspirate leukocytes: possible role in the development of bronchopulmonary dysplasia in premature infants.
    Mody K, Saslow JG, Kathiravan S, Eydelman R, Bhat V, Stahl GE, Pyon K, Bhandari V, Aghai ZH.
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1483-7. PubMed ID: 22272724
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary endostatin perinatally and in lung injury of the newborn infant.
    Janér J, Andersson S, Haglund C, Lassus P.
    Pediatrics; 2007 Jan; 119(1):e241-6. PubMed ID: 17158946
    [Abstract] [Full Text] [Related]

  • 8. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K, National Institutes of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [Abstract] [Full Text] [Related]

  • 9. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, COIN Trial Investigators.
    N Engl J Med; 2008 Feb 14; 358(7):700-8. PubMed ID: 18272893
    [Abstract] [Full Text] [Related]

  • 10. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.
    Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE.
    Pediatr Pulmonol; 2004 Feb 14; 37(2):137-48. PubMed ID: 14730659
    [Abstract] [Full Text] [Related]

  • 11. Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide.
    Truog WE, Ballard PL, Norberg M, Golombek S, Savani RC, Merrill JD, Parton LA, Cnaan A, Luan X, Ballard RA, Nitric Oxide (to Prevent) Chronic Lung Disease Study Investigators.
    Pediatrics; 2007 Apr 14; 119(4):670-8. PubMed ID: 17403837
    [Abstract] [Full Text] [Related]

  • 12. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project On Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997.
    Stoelhorst GM, Rijken M, Martens SE, Brand R, den Ouden AL, Wit JM, Veen S, Leiden Follow-Up Project on Prematurity.
    Pediatrics; 2005 Feb 14; 115(2):396-405. PubMed ID: 15689337
    [Abstract] [Full Text] [Related]

  • 13. Increase in cord blood soluble E-selectin and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia.
    Kim BI, Lee HE, Choi CW, Jo HS, Choi EH, Koh YY, Choi JH.
    J Perinat Med; 2004 Feb 14; 32(3):282-7. PubMed ID: 15188806
    [Abstract] [Full Text] [Related]

  • 14. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P, Simm M, Kumari J, Califano C, Aghai Z, Laborada G, Sison C, Cunningham-Rundles S.
    Pediatr Pulmonol; 2003 May 14; 35(5):392-9. PubMed ID: 12687597
    [Abstract] [Full Text] [Related]

  • 15. Increased interleukin-8 and monocyte chemoattractant protein-1 concentrations in mechanically ventilated preterm infants with pulmonary hemorrhage.
    Baier RJ, Loggins J, Kruger TE.
    Pediatr Pulmonol; 2002 Aug 14; 34(2):131-7. PubMed ID: 12112780
    [Abstract] [Full Text] [Related]

  • 16. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
    Cederqvist K, Sirén V, Petäjä J, Vaheri A, Haglund C, Andersson S.
    Pediatrics; 2006 Apr 14; 117(4):1226-34. PubMed ID: 16585319
    [Abstract] [Full Text] [Related]

  • 17. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
    Falciglia HS, Johnson JR, Sullivan J, Hall CF, Miller JD, Riechmann GC, Falciglia GA.
    Am J Perinatol; 2003 Feb 14; 20(2):97-107. PubMed ID: 12660915
    [Abstract] [Full Text] [Related]

  • 18. [Bronchopulmonary dysplasia--a one-year material].
    Farstad T, Bratlid D.
    Tidsskr Nor Laegeforen; 1990 Aug 20; 110(19):2524-7. PubMed ID: 2219011
    [Abstract] [Full Text] [Related]

  • 19. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone.
    Aghai ZH, Faqiri S, Saslow JG, Nakhla T, Farhath S, Kumar A, Eydelman R, Strande L, Stahl G, Leone P, Bhandari V.
    J Perinatol; 2008 Feb 20; 28(2):149-55. PubMed ID: 18033304
    [Abstract] [Full Text] [Related]

  • 20. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia.
    Cogo PE, Zimmermann LJ, Pesavento R, Sacchetto E, Burighel A, Rosso F, Badon T, Verlato G, Carnielli VP.
    Crit Care Med; 2003 May 20; 31(5):1532-8. PubMed ID: 12771629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.